Semiannual Report | February 28, 2019

Health Care (4.3%) *,^ Ligand Pharmaceuticals Inc. 85,505 10,609 * Syneos Health Inc. 198,420 8,288 * Myriad Genetics Inc. 144,173 4,474 Financial Statements (unaudited) Statement of Net Assets As of February 28, 2019 The fund reports a complete list of its holdings in regulatory filings four times in each fiscal year, at the quarter-ends. ................
................